2023 Full Year Guidance
Reconciliation of GAAP to non-GAAP financial measures
Shareholders' net income and diluted earnings per share
Three Months Ended December 31, 2022
Dollars in millions
Pre-Tax
Diluted earnings per
share
Dollars in millions
Diluted earnings per
share
Pre-Tax
After-Tax
After-Tax
$1,169
$3.83
Shareholders' net income
Adjustments to reconcile to
adjusted income from operations:
Net realized investment (gains)*
$(8)
$(0.03)
$(12)
$(0.04)
Amortization of acquired
$457
$1.50
$284
$0.93
intangible assets
Special items
Integration and transaction-related costs
$23
$0.08
$17
$0.06
Loss on sale of business
$73
$0.23
$56
$0.18
Adjusted income from operations
$1,514
$4.96
*Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.
Confidential, unpublished property of Cigra. © 2023 CignaView entire presentation